Medication info
Parotin Tablet 10 mg (Atorvastatin Calcium Trihydrate)

Parotin Tablet 10 mg (Atorvastatin Calcium Trihydrate)

Prescription medicationTabletOral
Ingredient · strength
Atorvastatin Calcium Trihydrate›10.85mg / 1 tablet
Manufacturer / importer
Pharmaking Co., Ltd.
Appearance
White oval film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201306119 · Approved 2013.03.11 · Insurance code 652301150

Summary

Main use
Improvement of hyperlipidemia; prevention of cardiovascular diseases (such as myocardial infarction and stroke)
Who takes it
Adults · Children
Adult dose
Patients receiving atorvastatin should follow a standard cholesterol-lowering diet before and during treatment. This medicine may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. For patients requiring a greater reduction in LDL cholesterol, treatment may be initiated at 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or greater is required). This medicine is administered at a dose of 10 ~ 80 mg once daily. The initial and maintenance doses of this medicine should be individualized according to the patient's characteristics, taking into account treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after treatment initiation and/or dose titration, and the dose adjusted accordingly. Since the goal of treatment is to lower LDL cholesterol, LDL cholesterol levels are recommended for use when initiating treatment and evaluating response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor treatment response. Patients with homozygous familial hypercholesterolemia This medicine is administered at a dose of 10 ~ 80 mg once daily, in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are not possible. ○ Patients with renal impairment: Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, dose adjustment is not necessary. ○ Older adults: The efficacy and safety in patients aged 70 years or older are similar to those in the general adult patient population.
Child dose
10 ~ 17 years: The recommended initial dose is 10 mg of this medicine once daily, and the recommended maximum dose is 20 mg once daily (there are no clinical data on doses of this medicine greater than 20 mg in pediatric patients). The dose should be adjusted as appropriate according to the recommended treatment goals for each patient. Dose adjustments should be made at intervals of 4 weeks or longer.

Ingredients

Manufacturer
Pharmaking Co., Ltd.

Efficacy & effects

Improvement of hyperlipidemia; prevention of cardiovascular diseases (such as myocardial infarction and stroke)

  • Coronary heart disease
  • myocardial infarction
  • stroke
  • revascularization
  • chronic stable angina
  • retinopathy
  • albuminuria
  • hypertension
  • type 2 diabetes
  • congestive heart failure
  • angina
  • hyperlipidemia
View approved original text

This medication helps reduce the risk of cardiovascular diseases. In particular, it lowers the risk of myocardial infarction and stroke in adults with risk factors for coronary heart disease or patients with type 2 diabetes, and it also reduces the risk of revascularization and angina. Additionally, in patients who already have coronary heart disease, it effectively reduces the associated risks of myocardial infarction, stroke, congestive heart failure, and angina. This drug is also used for the treatment of hyperlipidemia, lowering total cholesterol, LDL cholesterol, and triglyceride levels while increasing HDL cholesterol levels, providing help to various patients with dyslipidemia. It can also be used alongside dietary therapy to improve cholesterol levels in pediatric patients with heterozygous familial hypercholesterolemia. Therefore, this medication is widely used to improve cardiovascular disease and hyperlipidemia risk factors.

How to take

Adult dose

Patients receiving atorvastatin should follow a standard cholesterol-lowering diet before and during treatment. This medicine may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. For patients requiring a greater reduction in LDL cholesterol, treatment may be initiated at 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or greater is required). This medicine is administered at a dose of 10 ~ 80 mg once daily. The initial and maintenance doses of this medicine should be individualized according to the patient's characteristics, taking into account treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after treatment initiation and/or dose titration, and the dose adjusted accordingly. Since the goal of treatment is to lower LDL cholesterol, LDL cholesterol levels are recommended for use when initiating treatment and evaluating response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor treatment response. Patients with homozygous familial hypercholesterolemia This medicine is administered at a dose of 10 ~ 80 mg once daily, in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are not possible. ○ Patients with renal impairment: Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, dose adjustment is not necessary. ○ Older adults: The efficacy and safety in patients aged 70 years or older are similar to those in the general adult patient population.

Child dose

10 ~ 17 years: The recommended initial dose is 10 mg of this medicine once daily, and the recommended maximum dose is 20 mg once daily (there are no clinical data on doses of this medicine greater than 20 mg in pediatric patients). The dose should be adjusted as appropriate according to the recommended treatment goals for each patient. Dose adjustments should be made at intervals of 4 weeks or longer.

Precautions

This medication may cause abnormalities in the muscles; thus, if muscle pain or weakness occurs, you must inform your doctor immediately. If severe muscle damage or rhabdomyolysis is suspected, treatment should be stopped, and patients with weakened kidney function should be particularly cautious. This medication should not be used by patients with allergic reactions to it, those with active liver disease, pregnant or breastfeeding women, or children under the age of 10. Caution is also warranted for patients with poor liver function or a history of liver disease, such as alcoholics, and they should undergo regular liver function tests. The blood concentration of this medication may increase or decrease when taken with certain drugs, so you must inform your doctor or pharmacist if you are taking other medications. Women of childbearing age should use appropriate contraception while taking this medication, and if pregnancy is confirmed, treatment should be interrupted immediately. This medication should be taken with caution, including avoiding grapefruit juice, which may increase its blood concentration. Elderly patients or those with kidney impairment are at higher risk of myopathy and should be monitored closely. In case of overdose, there is no specific antidote, and treatment should be symptomatic while monitoring liver function and muscle enzyme levels. Store out of reach of children and keep in the original container for safety.

Side effects

Weakness, lethargy, chest pain, peripheral edema, fatigue, fever, rhinitis, hyperglycemia, hypoglycemia, weight gain, appetite loss, constipation, abdominal distension, indigestion, nausea, diarrhea, abdominal pain, vomiting, belching, pancreatitis, pharyngitis, laryngitis, epistaxis, insomnia, nightmares, headache, dizziness, paresthesia, sensory loss, dysgeusia, memory loss, peripheral neuropathy, myalgia, arthralgia, limb pain, musculoskeletal pain, muscle cramps, joint swelling, back pain, neck pain, muscle fatigue, complications due to rupture, myopathy, myositis, rhabdomyolysis, tendon disorders, muscle rupture, lupus-like syndrome, immune-mediated necrotizing myopathy, thrombocytopenia, vasculitis, allergic reaction, anaphylaxis, hepatitis, cholestasis, liver failure, blurred vision, visual impairment, tinnitus, hearing loss, urticaria, skin rash, itching, hair loss, angioedema, vascular neurogenic edema, erythema multiforme, mucocutaneous syndrome, toxic epidermal necrolysis, gynecomastia, abnormal liver function tests, increased serum CK, positive urinary leukocytes, leukopenia, anemia, decreased testosterone, increased cholinesterase, increased TSH, increased ACTH, decreased aldosterone, elevated potassium, increased BUN, cerebral infarction, palpitations, tachycardia, vomiting, abdominal abnormalities, hepatitis, cholestasis, cholestatic jaundice, abnormal liver function test results, gastroenteritis, enteritis, dry mouth, rectal bleeding, esophagitis, belching, glossitis, oral ulcers, stomatitis, gallbladder pain, cheilitis, gastric and duodenal ulcers, dysphagia, melena, gum bleeding, postural orthostatic tachycardia syndrome, bronchitis, rhinitis, pneumonia, dyspnea, asthma, sensory disturbance, vertigo, photosensitivity reaction, drowsiness, forgetfulness, abnormal dreams, decreased libido, emotional instability, ataxia, torticollis, facial paralysis, hyperkinesia, depression, hypertonia, myositis, muscle disease, arthritis, bursitis, tenosynovitis, myasthenia gravis, tendon contracture, increased serum myoglobin, contact dermatitis, dry skin, sweating, acne, eczema, seborrhea, skin ulcer, erectile dysfunction, urinary tract infection, frequent urination, cystitis, hematuria, dysuria, nephrolithiasis, nocturia, epididymitis, breast fibrocystic disease, vaginal bleeding, albuminuria, breast enlargement, cervical secretions, nephritis, urinary incontinence, urinary retention, urgency, abnormal ejaculation, uterine bleeding, colored urine, hypothermia, hypertriglyceridemia, facial flushing, increased non-protein nitrogen, hyperuricemia, gingival hyperplasia, sleep disturbances, memory loss, depression, interstitial lung disease, sexual dysfunction, diabetes, cognitive impairment, muscle weakness, ocular myasthenia, elevated AST

Not everyone experiences these, and they can vary from person to person.

Storage

This medication must be stored in a tightly sealed container to avoid exposure to air or moisture. It is important to maintain a storage temperature between 1 and 30 degrees Celsius. Avoid storing in places that are too hot or too cold, and keep it in a cool place away from direct sunlight.

Appearance and packaging

Appearance

White oval film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.